abstract |
FIELD: chemistry.SUBSTANCE: invention relates to biochemistry, in particular to a pharmaceutical composition containing an isolated antibody or its antigen-binding fragment, which specifically binds to alpha-toxin (AT), and recovered antibody or its antigen-binding fragment, which specifically binds to antigen, which is a surface determinant selected from a group consisting of IsdH and ClfA. Also disclosed is a method of treating an infectionusing said composition, a method of reducing bacterial agglutinationusing said composition.EFFECT: invention has the ability effectively treat infections.9 cl, 11 ex, 7 tbl, 18 dwg |